Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: Study protocol of the IPOP randomized trial

UNC Libraries(2020)10.17615/8534-m172Source: DataRank Database

Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: Study protocol of the IPOP randomized trial is a research paper published in UNC Libraries (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.00)OA: greenTopics (46)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

F.M. Mbewe,D.J. Rouse,E. Chomba,H.B. Mulenga,J.T. Price

Live enrichment

PubMed:19162232 OpenAlex:https://openalex.org/W4289008399

National Institutes of Health

Grant: 5T32HD075731-05

UNC Global Women's Health Fellowship

National Institutes of Health

Grant: 5K01TW010857-03

A Career Development Award in HIV-Associated Preterm Birth and its Prevention

National Institutes of Health

Grant: 5R01HD087119-02

A Randomized Trial of 17-Hydroxyprogesterone Caproate (17P) to Reduce Preterm Birth Among Women Receiving Antiretroviral Therapy in Pregnancy

FWCI

0.00

Citation Percentile

0.3%

greenLicense: CC BY

repositoryhttps://doi.org/10.17615/8534-m172

https://doi.org/10.1186/s12884-019-2224-8

https://bmcpregnancychildbirth.biomedcentral.com/track/pdf/10.1186/s12884-019-2224-8

https://dx.doi.org/10.17615/8534-m172

https://dx.doi.org/10.7916/d8-b32z-q748

Fields of Study

Preterm Birth and ChorioamnionitisBreastfeeding Practices and InfluencesReproductive tract infections research03 medical and health sciences0302 clinical medicine

Keywords

MedicineRandomized controlled trialObstetricsProtocol (science)Human immunodeficiency virus (HIV)GynecologyInternal medicineVirologyAlternative medicineAnti-HIV Agents61017-alpha hydroxyprogesterone caproateZambiaGestational AgeHIV InfectionsInjections, IntramuscularDeveloping countries618Study ProtocolPregnancyHydroxyprogesterone17 alpha-Hydroxyprogesterone CaproatePremature laborHumansPregnancy Complications, InfectiousProgesteroneRandomized Controlled Trials as TopicSub-Saharan AfricaHIVPreterm birthGynecology and obstetricsStillbirthAntiretroviral therapyClinical Trials, Phase III as TopicHIV-positive womenRG1-991Premature BirthFemaleProgestinsPrenatal careLive Birth

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Gender equality